Tiverton Asset Management’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-33,688
Closed -$1.13M 475
2018
Q1
$1.13M Sell
33,688
-145,987
-81% -$4.4M 0.08% 144
2017
Q4
$5.54M Sell
179,675
-51,069
-22% -$1.55M 0.35% 78
2017
Q3
$6.7M Sell
230,744
-29,144
-11% -$749K 0.38% 81
2017
Q2
$6.74M Sell
259,888
-86,637
-25% -$2.07M 0.36% 88
2017
Q1
$8.52M Hold
346,525
0.44% 80
2016
Q4
$8.58M Hold
346,525
0.51% 76
2016
Q3
$7.27M Sell
346,525
-251,475
-42% -$5.38M 0.58% 65
2016
Q2
$18.7M Buy
598,000
+32,352
+6% +$603K 0.79% 43
2016
Q1
$10.7M Sell
565,648
-50,152
-8% -$955K 0.36% 85
2015
Q4
$13.1M Hold
615,800
0.41% 76
2015
Q3
$10.4M Hold
615,800
0.23% 96
2015
Q2
$11M Hold
615,800
0.22% 106
2015
Q1
$10.8M Sell
615,800
-3
-0% -$55 0.22% 100
2014
Q4
$11.5M Hold
615,803
0.24% 95
2014
Q3
$9.12M Hold
615,803
0.21% 97
2014
Q2
$9.35M Hold
615,803
0.21% 98
2014
Q1
$10.4M Hold
615,803
0.23% 100
2013
Q4
$10.6M Buy
615,803
+3
+0% +$52 0.23% 96
2013
Q3
$9.35M Hold
615,800
0.23% 94
2013
Q2
$8.55M Buy
+615,800
New +$8.13M 0.22% 90

Other funds holding NEOG

Tiverton Asset Management's NEOG Position: Q2 2018 in Review

Tiverton Asset Management sold out of Neogen (NEOG) in Q2 2018, closing a stake of 33,688 shares — an estimated $1.13M sold.

Tiverton Asset Management first reported a position in NEOG in Q2 2013 and held it in 20 quarters. The position peaked at $18.7M in Q2 2016. 258 funds tracked by Wall St. Rank hold NEOG as of Q2 2018.

  • Tiverton Asset Management reported no remaining Neogen position as of Q2 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 33,688 Neogen shares in Q2 2018, an estimated $1.13M.
  • Tiverton Asset Management first reported a position in Neogen in Q2 2013 and held it in 20 quarters.
  • Tiverton Asset Management's Neogen position peaked at $18.7M in Q2 2016.
  • 258 funds tracked by Wall St. Rank held Neogen as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.